Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; this is a minor UI/system update that does not change the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no substantive changes to the study content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange Detected- Results Submitted: The study page now shows that results have been submitted for NCT03210662. The previous 'No Results Posted' indicator and the government funding status notice have been removed.SummaryDifference0.5%

- Check42 days agoChange DetectedNo meaningful updates detected on the Study Details page for NCT03210662; the core content remains unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference3%

- Check78 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.